These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 16751170)

  • 1. Efficacy and safety of butterbur herbal extract Ze 339 in seasonal allergic rhinitis: postmarketing surveillance study.
    Käufeler R; Polasek W; Brattström A; Koetter U
    Adv Ther; 2006; 23(2):373-84. PubMed ID: 16751170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treating intermittent allergic rhinitis: a prospective, randomized, placebo and antihistamine-controlled study of Butterbur extract Ze 339.
    Schapowal A;
    Phytother Res; 2005 Jun; 19(6):530-7. PubMed ID: 16114089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomised controlled trial of butterbur and cetirizine for treating seasonal allergic rhinitis.
    Schapowal A;
    BMJ; 2002 Jan; 324(7330):144-6. PubMed ID: 11799030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A newly developed extract (Ze 339) from butterbur (Petasites hybridus L.) is clinically efficient in allergic rhinitis (hay fever).
    Brattström A
    Phytomedicine; 2003; 10 Suppl 4():50-2. PubMed ID: 12807342
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of Early Allergic and Late Inflammatory Symptoms of Allergic Rhinitis with
    Blosa M; Uricher J; Nebel S; Zahner C; Butterweck V; Drewe J
    Pharmaceuticals (Basel); 2021 Feb; 14(3):. PubMed ID: 33668395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Petasites--Zeller: ZE 339.
    Drugs R D; 2003; 4(6):378-9. PubMed ID: 14584971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of butterbur treatment in intermittent allergic rhinitis: a placebo-controlled evaluation.
    Gray RD; Haggart K; Lee DK; Cull S; Lipworth BJ
    Ann Allergy Asthma Immunol; 2004 Jul; 93(1):56-60. PubMed ID: 15281472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Butterbur Ze339 for the treatment of intermittent allergic rhinitis: dose-dependent efficacy in a prospective, randomized, double-blind, placebo-controlled study.
    Schapowal A;
    Arch Otolaryngol Head Neck Surg; 2004 Dec; 130(12):1381-6. PubMed ID: 15611396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The butterbur extract petasin has no effect on skin test reactivity induced by different stimuli: a randomized, double-blind crossover study using histamine, codeine, methacholine, and aeroallergen solutions.
    Gex-Collet C; Imhof L; Brattström A; Pichler WJ; Helbling A
    J Investig Allergol Clin Immunol; 2006; 16(3):156-61. PubMed ID: 16784008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the drug monitoring programme of azelastine hydrochloride nasal spray in the treatment of allergic rhinitis in children under 13 years of age.
    Wober W; Diez Crespo CD; Bähre M
    Arzneimittelforschung; 1997 Jul; 47(7):841-4. PubMed ID: 9272242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multicenter clinical trials on a novel polyherbal formulation in allergic rhinitis.
    Saxena VS; Venkateshwarlu K; Nadig P; Barbhaiya HC; Bhatia N; Borkar DM; Gill RS; Jain RK; Katiyar SK; Nagendra Prasad KV; Nalinesha KM; Nasiruddin K; Rishi JP; Roy Chowdhury J; Saharia PS; Thomas B; Bagchi D
    Int J Clin Pharmacol Res; 2004; 24(2-3):79-94. PubMed ID: 15689054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Butterbur, a herbal remedy, attenuates adenosine monophosphate induced nasal responsiveness in seasonal allergic rhinitis.
    Lee DK; Carstairs IJ; Haggart K; Jackson CM; Currie GP; Lipworth BJ
    Clin Exp Allergy; 2003 Jul; 33(7):882-6. PubMed ID: 12859442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety of a patented special butterbur root extract for migraine prevention.
    Danesch U; Rittinghausen R
    Headache; 2003 Jan; 43(1):76-8. PubMed ID: 12864764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fexofenadine is efficacious and safe in children (aged 6-11 years) with seasonal allergic rhinitis.
    Wahn U; Meltzer EO; Finn AF; Kowalski ML; Decosta P; Hedlin G; Scheinmann P; Bachert C; Rosado Pinto JE; Baena-Cagnani C; Potter P; Simons FE; Ruuth E
    J Allergy Clin Immunol; 2003 Apr; 111(4):763-9. PubMed ID: 12704355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Petasol butenoate complex (Ze 339) relieves allergic rhinitis-induced nasal obstruction more effectively than desloratadine.
    Dumitru AF; Shamji M; Wagenmann M; Hindersin S; Scheckenbach K; Greve J; Klenzner T; Hess L; Nebel S; Zimmermann C; Zahner C; Schmidt-Weber CB; Chaker AM
    J Allergy Clin Immunol; 2011 Jun; 127(6):1515-21.e6. PubMed ID: 21489609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the clinical efficacy and safety of grapeseed extract in the treatment of fall seasonal allergic rhinitis: a pilot study.
    Bernstein DI; Bernstein CK; Deng C; Murphy KJ; Bernstein IL; Bernstein JA; Shukla R
    Ann Allergy Asthma Immunol; 2002 Mar; 88(3):272-8. PubMed ID: 11926620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Double-blind trials of azelastine nasal spray monotherapy versus combination therapy with loratadine tablets and beclomethasone nasal spray in patients with seasonal allergic rhinitis. Rhinitis Study Groups.
    Berger WE; Fineman SM; Lieberman P; Miles RM
    Ann Allergy Asthma Immunol; 1999 Jun; 82(6):535-41. PubMed ID: 10400480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MP29-02 (a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate) in the treatment of seasonal allergic rhinitis: a randomized, double-blind, placebo-controlled trial of efficacy and safety.
    Meltzer EO; LaForce C; Ratner P; Price D; Ginsberg D; Carr W
    Allergy Asthma Proc; 2012; 33(4):324-32. PubMed ID: 22856633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized placebo-controlled trial comparing fluticasone aqueous nasal spray in mono-therapy, fluticasone plus cetirizine, fluticasone plus montelukast and cetirizine plus montelukast for seasonal allergic rhinitis.
    Di Lorenzo G; Pacor ML; Pellitteri ME; Morici G; Di Gregoli A; Lo Bianco C; Ditta V; Martinelli N; Candore G; Mansueto P; Rini GB; Corrocher R; Caruso C
    Clin Exp Allergy; 2004 Feb; 34(2):259-67. PubMed ID: 14987306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Allergo-immunology].
    Leimgruber A
    Rev Med Suisse; 2006 Jan; 2(48):89-92. PubMed ID: 16463791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.